BB vs COLL
BlackBerry Ltd (BB) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BB currently screens at market cap $6.14B and trailing P/E 116.5. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BB and COLL stock pages for the full models.
Not investment advice.